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Summary.-Twice-weekly intratracheal instillations in rats of up to 24 mg of
Fraction (R + P)G suspended in either infusine (I) or buffered saline/gelatine
(BS/G) gave rise to foci of squamous metaplasia of alveolar epithelium (SqM) and
squamous neoplasms (SqN). Fraction (R + P)G, which is a fraction of cigarette-
smoke condensate almost as tumorigenic for mouse skin as the nearly 30x larger
mass of condensate from which it is derived, could be given in this way for up to
40 weeks without excessive mortality or any marked effect on the rate of body-weight
gain. By contrast, similar treatment with Fraction N(QG), a fraction having very
low tumorigenic activity for mouse skin, induced no SqN and barely any excess of
SqM over that induced by either vehicle alone.
The effects of Fraction (R + P)G on the incidence of SqM and SqN were both time
and dose related, the effect on SqM incidence being already evident after 10 weeks of
treatment. No SqN seen were unequivocally malignant, though, due to the design
of the experiment, only 5 rats exposed to Fraction (R + P)G were observed more
than 60 weeks after the start of the experiment.
Other changes in the lung, including aggregates of alveolar macrophages laden
with golden-brown pigment (GBM) and foci of cuboidal/columnar metaplasia of
alveolar epithelium (CCM), were frequently seen in response to both fractions.
Fraction (R + P)G administered in I was more effective in causing SqM and SqN
than the same fraction administered in BS/G. The implications of the findings are
discussed, particularly the possibility that the intratracheal/instillation technique
might be useful as a rapid bioassay for comparing the tumorigenicity of different
cigarette-smoke condensates.
DESPITE several attempts, malignant
tumours have not been produced in
significant numbers in the lungs of
experimental animals by exposing them
to cigarette smoke (Dontenwill et al.,
1973; Bernfield et al., 1974; Davis et al.,
1975a). Lung tumours have been readily
induced by carcinogens administered by
intratracheal instillation (Shabad, 1962;
Pylev, 1963; Schreiber et al., 1972; Davis
et al., 1975b). Davis et al. (1975c) also
showed that the repeated fortnightly
instillation of cigarette-smoke condensate
(SWS) was associated with increased
incidence of cuboidal columnar meta-
plasia (CCM) and squamous metaplasia
(SqM), although such treatment failed to
induce squamous neoplasms (SqN) in the
lungs. Certain fractions of SWS known to
be carcinogenic to mouse skin also pro-
duced CCM and SqM. In addition, Frac-
tion P(SG), which contains most of the
polycyclic aromatic hydrocarbons of
cigarette smoke, produced a low incidence
of benign or doubtfully malignant SqN,
similar to those induced by the known
carcinogen, benz(a)pyrene.
The object of the first experimentP. J. SIMONS, P. N. LEE AND F. J. C. ROE
described in the present report was to
determine whether rats will tolerate more
frequent intratracheal instillations of
SWS or smoke-condensate fractions and,
if so, whether such treatment leads to the
early development of SqN, or a high
incidence of SqN, and/or to the develop-
ment of SqN of undoubted malignancy.
The object ofthe second experiment was
to compare the effects on rat lung of 2
fractions of tobacco-smoke condensate,
one of which (Fraction (R + P)GC) is far
more tumorigenic for mouse skin than the
other (Fraction N(QG)).
MATERIALS AND METHODS
Rats.-Non-inbred Wistar specific-patho-
gen-free (SPF) rats obtained from Olac
(Southern) Ltd, of Blackthorn, near Bicester,
Oxon, were used for the 2 main experiments.
Non-inbred Wistar SPF rats bred in our own
laboratories (strain TRCL) were used for
preliminary short-term toxicity trials.
In each experiment, female rats aged 12
weeks were allocated by a non-selective
process to the various treatment groups.
Animals were housed in groups of 5 in solid-
floor polypropylene cages with sawdust
bedding, in natural daylight at 22 ± 3°C.
They were fed Oxoid 41B laboratory animal
diet and water ad libitum.
Preparation of condensate and fractions.-A
single batch of plain cigarettes (TRC code
T57) manufactured from a composite blend
of flue-cured tobacco was used as the source
for all condensate.
Smoke condensate was prepared by smok-
ing cigarettes in the automatic smoking
machine described by Day (1967). The
standard smoking parameters used were: puff
volume, 35 ml; puff duration, 2 s; puff
frequency, 1 min; butt length, 20 mm. Smoke
was collected in a glass trap cooled by
immersion in acetone and crushed solid CO2
(Davies and Day, 1969). It was stored at
-29°C until used. Such a condensate was
referred to as "stale whole-smoke condensate"
(SWS).
The fractionation scheme has been de-
scribed in detail (Whitehead and Rothwell,
1969; Lee et al., 1977). The origins of the
fractions used in these experiments were:
Fractions G, (R + P)Gand Q(G).-Prepared
from SWS by removal of the water-soluble
materials and subsequent distribution of the
water-insoluble residue (Fraction C) between
9000 v/v aqueous methanol and cyclohexane
(Fraction G). The caffeine-complexing
material (Fraction (R + P)G) was removed
by extracting fraction G dissolved in cyclo-
hexane with a solution of caffeine in aqueous
9000 formic acid to leave a residual fraction
Q(G).
Fractions K(QG) and L(QG).-Prepared by
distribution of Fraction Q(G) between cyclo-
hexane and dimethyl sulphoxide (DMSO).
Fraction HC(QG).-Prepared by adsorption
of Fraction Q(G) on an alumina column,
followed by elution with petroleum ether and
benzene.
Fractions N(QG) and M(QG).-Prepared by
shaking a solution of Q(G) in benzene with
de-activated silica gel. Fraction N(QG) was
recovered from the benzene and Fraction
M(QG) from the silica by elution with
methanol.
Chemicals. Dotriacontane was obtained
from Koch-Light Labs. Ltd, and hexadecane
from BHD Ltd. Both chemicals were re-
crystallized before use.
Infusine as described in Davis et al. (1975a)
was used as the vehicle in most experiments.
In the second main experiment phosphate-
buffered saline (pH 7.4) containing 2%
gelatine was used as one of the vehicles. This
vehicle is referred to as ' BS/G" in the
Tables.
Treatment and observation.-The method
for intratracheal instillation is described in
Davis et al. (1975a). Animals were inspected
daily for state of general health, clinically
examined at the times of treatment, and
weighed wveekly. The techniques for post
mortem examination and microscopic exam-
ination of tissues are described in Davis et al.
(1975a).
Histopathological evaluation.-All rats that
died or were killed during or at the end ofthe
experiments were examined post mortem.
Four standard 6 um sections were prepared
of the lungs of rats showing no localized
lesions at necropsy. Additional sections were
taken through macroscopically visible
tumours, unless these were adequately
represented in standard sections. Sections
wvere stained with haematoxylin and eosin
and scored in respect of 4 kinds of lesion: (i)
aggregates of brown-pigment-laden alveolar
macrophages (GBM); (ii) foci of cuboidal/
columnar metaplasia of alveolar epithelium
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(CCM); (iii) foci of squamous metaplasia of
alveolar epithelium (SqM) and iv) squamous
neoplasms (SqN). Slightly different scoring
systems were used in the 2 experiments, and
details are given separately in the text
describingeachexperiment. Histopathological
evaluations were blind", in the sense that
the pathologist (FJCR) w%as unaware of the
treatment rats had received or of the week
of the experiment in which they died or wi-ere
killed.
Statistical evaluation.- Significance tests
wvere carried out to assess between-group
differences of 3 different parameters: (i) pro-
portion of rats with a given lesion; (ii) mean
number of lesions per rat and (iii) mean grade
oflesion per rat. Ifthe results being considered
were based on rats dying in a single interval,
chi-squared analysis w%as used for the first
parameters and one-wTay analysis of variance
for the second or third parameters. If a
simultaneous assessment of results from rats
dying in more than one interval was being
made, Peto's method for incidental tumours
(1974) was used for the first parameter, in
order to correct for possible differences in
survival between the groups. The other 2
parameters w%ere analysed by unbalanrced
two-wayanalysis ofvariance, to give between-
group differences "adjustedfortimeofdeath".
All analyses ofvariance were carried out after
a suitable variance-stabilizing transformation
of the data. For the second parameters,
which are counts, the square-root trans-
formation y=V/x -,as used, while for the
third parameters, w%hich are scores out of a
maximum possible (M) the transformnation
y = loge[(x + 1)/(M + 1 - x)] was used.
Analysis of variance, this time of untrans-
formed data, was also used to compare
groups in terms of body weight and body-
w-eight gain.
EXPERIMENTAL I)ESIGN ANT) RESULTS
Experiment I
Preliminary toxicity studies showed
that rats would tolerate twice-weekly
intratracheal instillations of 12 mg of
Fraction (R + P)G in infusine, but not
similar exposure to whole condensate
(SWS) or Fraction G(. The purpose of Exp.
I was to see whether even higher doses of
(R + P)G would be tolerated, and if so
what effects such treatment would have.
Seventy rats were allocated non-selec-
tively to 3 treatment groups, each of 18
animals, and 3 control groups, each of
4-6 animals. Rats in the first 3 groups
received twice-weekly instillation of 12 mg,
24 mg or 48 mg of Fraction (R + P)G in
infusine (total volume per instillation =
0 2 ml). One control group (6 rats) was
similarly exposed to infusine only; another
control group (6 rats) was anaesthetized
twice-weekly but received no treatment;
and the remaining control group (4 rats)
received neither anaesthetic nor treatment.
Treatment continued for 34 weeks, after
which a proportion of the survivors were
killed. The remaining rats were observed
until the termination of the experiment at
84 weeks. The design of the study is
TABLE I. Survival of Rats Given up to 69 Twice-weekly Doses of Fraction (R + P)G
Prepared from, Cigarette TRC/57 by Intratracheal Instillation
Killed at No. survivors Killed at
No. survivors at Week :34 weeks for at Week 84 weeks for
Treatment -, histopathological - histopathological
Grouip (2 x weekly) 0 10 2() 34 examination 34+ 60 examination
1 l2mg(R+P)G 18 17 14 13 9 4 :3 1
in infusine
2 24 mg(R -1 P)G
in infuLsinle
3 48mg(R + P)G
in iinfusine
4 Iinfuisiine only
5 Anaesthetic only
6 None
18 18 16 14 9
18 18 8 ,I)
6 6 6 6 2
6 ,5 5 4 2
4 4 4 4 0
.5 2 0
0 0 ~~~0
4 4 3
2 1 0
4 4 4
27 19 14 8
967
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TABLE II.-Mean Initial Body Weight
Treatment
(2 x weekly)
12 mg (R + P)G
in infusine
24 mg (R + P)G
in infusine
48 mg (R + P)G
in infusine
Infusine only
Anaesthetic only
None
Mean
s.e.
Mean
s.e.
Mean
s.e.
Mean
s.e.
Mean
s.e.
Mean
s.e.
Initial
body weight
229 -9
3 -6
228- 1
2 -8
220- 1
7 -4
239 -5
6-4
242 -3
4-3
228 -2
8-8
4
17 -2
1 -6
6-0
2 -0
4-2
1 -6
11-0
2 -9
10-0
2 -4
4-6
2-7
and Body-weight Gain
Weight gain by week
8
24-5
2-0
24-2
2 -4
19-8
2-7
28 -2
6-1
35-0
5 -4
28 -2
3 -5
16
43 -9
2-8
41 -4
3-7
40-4
2-0
51 -8
5 -4
51 -0
5-2
36-0
7-1
TABLE III.-Macroscopically Visible Lung Tumours (T) and Microscopically Observed
Squamous Neoplasms (SqN) in Rats Examined at Post Mortemt
No. rats with
Treatment
(2 x weekly)
12 mg (R + P)G in infusine
24 mg (R + P)G in infusine
48 mg (R + P)G in infusine
Combined control groups
Examined at
post mortem:
17
15
15
6
T SqN
0* E 0 E
3 4-53 7 9 - 62
5 4-45 11 9.59
4 3 -02 7 5-80
0 0
Mean no.
SqN/rat
0-47
1 -80
2-07
0
* 0 = Number observed; E = Number expected if the effects of the 3 dose levels had been the same,
after allowing for survival differences (see text).
t Allmacroscopically observed tumours were found onmicroscopic examination to be squamousneoplasms. However several small squamous neoplasms not observed at necropsy were discovered on microscopic
examination of the lungs.
t 7 treated rats in groups 1-3 were too autolysed for assessment and only 6 control rats (groups 4-6)
were assessed. Otherwise the Table refers to all rats in the experiment, irrespective of when they died or
were killed.
evident from Table I, which also gives
survival data.
Table I shows that twice-weekly intra-
tracheal instillations of 12 mg or 24 mg,
but not 48 mg, (R + P)G were well
tolerated in terms ofsurvival. As shown in
Table II, the mean body weight of rats in
all the groups increased during the study.
Analysis of variance showed that, though
there were marked differences between the
6 groups in weight gain in the first 4
weeks (P < 0-001) due mainly to a marked
dose-response trend, these were not sub-
sequently statistically significant. How-
ever the (R + P)G-treated groups had
consistently lower weight gains than the
infusine-only or anaesthetic-only groups.
The behaviour of the untreated group was
surprisingly erratic.
Tables III and IV summarize the find-
ings in terms of tumours observed macro-
scopically at necropsy and GBM, SqM and
SqN scores derived from a "blind"
histopathological evaluation of sections
from 53 of the 70 rats. The scoring system
used in this study was as follows. The
available sections of the lungs of each rat
were given an arbitrary GBM score of 0-4
according to an overall assessment of the
frequency of aggregates of pigment-laden
macrophages. Arbitrary CCM scores on a
0-4 scale and SqM on a 0-3 scale were
arrived at in a similar way. The squamous
neoplasms encountered consisted of large
masses of keratin surrounded by a narrow
zone of squamous epithelium. Apart from
their large size and excessive keratin
component, the lesions were difficult to
distinguish from squamous metaplasia.
Undoubtedly benign lesions were graded
"4" and lesions which showed possible
evidence of extension into surrounding
Group
1
2
3
4
5
6
32
55 -4
4-3
57-5
4-7
44-4
3 -9
65-5
3 -8
73 -5
8-3
61 -6
7 -6
Group
1
2
3
4,5, & 6
~~~~~~~A
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TABLE IV.-Microscopic Findings in Rats Killed at 34 Weeks
Treatment
(2 x weekly)
12 mg (R + P)G in infusine
24 mg (R + P)G in infusine
48 mg (R + P)G in infusine
Combined control groups
Mean grade of
I A
I
No. rats
9
9
5
4
GBM
3 -08
3 -36
2-70
0
CCM
3 03
3 5:3
3 *27
0 *50
SqM
1*58
2 -26
2 -49
0
lung tissue were graded "5". These grades
were a direct extension of the grades 0-3
used for SqM lesions.
The results in Table III show clearly
that tumours and SqN were related to the
(R + P)G treatment, none being seen in
any of the 6 control rats examined. After
taking between-group survival differences
into account, no statistically significant
side response was found in the numbers
with either tumour or SqN, though there
was some indication of a positive trend, as
indicated by the excess in the highest dose
levels in the observed numbers (0) over
those expected (E) under the assumption
that dose does not influence incidence.
There was, however, clear evidence of a
significant dose-related effect on the mean
number of SqN per rat, the mean number
in Group 1 being very significantly (P <
0.001) less than that in the other 2 groups.
As all 3 lesions studied in Table IV are
strongly time-related, the Table simplifies
the comparison of the groups by consider-
ing only those rats killed at Week 34.
Though (R + P)G itself had a marked
effect on all 3 types of lesion, there was
no clear evidence of a dose relationship in
the effects of treatment on mean GBM
and CCM scores. There was, however, a
very highly significant dose-related effect
on mean SqM score (P < 0f01).
Full examination of other organs at
necropsy revealed no evidence of meta-
stasis from any of the lung tumours.
Experiment II
The purpose of this experiment was to
compare the response of the rat lung to a
fraction of smoke condensate known to be
tumorigenic for mouse-skin ((R + P)G)
with that to one known to have little or
no tumorigenic effect. At the same time it
was proposed to compare the influence on
response of 2 different vehicles, infusine
(I) and buffered saline/gelatine (BS/G).
Preliminary toxicity studies were under-
taken to identify a suitable fraction of
smoke condensate which was not tumori-
genic for mouse-skin and which would be
tolerated by rats exposed to it by intra-
tracheal instillation. Short-term studies
indicated that Fractions K(QG), L(QG),
M(QG) and HC(QG), and also dotriacon-
tane, hexadecane and liquid paraffin
(BPC), were too toxic, but that Fraction
N(QG) might be sufficiently well-tolerated
for the purposes of the proposed study.
A preliminary short-term study was
also carried out to see whether the fre-
quency of dosing could be increased from
twice to 3 x weekly without an adverse
effect on survival of rats given 12 or 24 mg
of (R + P)G. The results showed that
mortality with 3 x weekly treatment was
excessive and it was, therefore, decided to
continue with 2 x weekly application in
Experiment II.
The design of Experiment II, involving
a comparison of the effects of Fractions
(R + P)G and N(QG) with I or BS/G as
vehicle is evident from Table V. The
Table shows that 309 rats were allocated
non-selectively to 15 groups, of which 46
died before Week 10, 47 from 9 different
groups were killed at 10 weeks, 10 died
between 10 and 20 weeks, 42 from 7
different groups were killed at 20 weeks,
7 died between 20 and 40 weeks, and the
remaining 157 were killed at 40 weeks.
From these figures it can be seen that
Fraction N(QG) at the dose levels 24 mg
or 12 mg twice weekly in I caused more
premature deaths than any other treat-
ment, and that Fraction (R + P)G at the
dose level of 24 mg twice weekly in BS/G
Group
1
2
:1
4,5 & 6
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TABLE V.-Experiment II: Design and Survival
Treatment
(mg 2 x weekly) No. of
for up to 40 weeks rats
24 234 12 (R + P)G in 24
3 infuisine 12
0 29
24 23
12 N(QC) in 20
6 rinfusine 10
3 12
24' 35
12 (R + )G in 24
6 BS/G 10 3 j 12
0J 30
Anaesthetic Control 22
Died
before
Week 10
4
1
2
1
2
11
11
I 1
7
0
1
1
3
0
No.
killed at
10 weeks
6
6
0
0
6
4
4
0
0
6
6
0
0
:3
6
Died
between
10 and 20
weeks
1
0
0
0
0
3
.3
2
0
1
0
0
0
0
0
No.
killed at
20 weeks
6
6
0
0
6
0
0
0
0
6
6
0
0
6
6
Died
between
20 and 40
weeks
0
0
0
0
1
0
2
0
2
0
0
1
0
309 46
caused more deaths than when I was the
vehicle (10 vs 5).
There were no striking differences
between groups in rate of body-weight
gain during the experiment, except that
the anaesthetic control group (Group 15)
put on more weight (60 g) between the 4th
and 40th weeks ofthe experiment than any
other group (range 32-50 g).
Groups were compared in respect of (i)
incidence of macroscopically visible lung
tumours, (ii) severity ofchronic respiratory
diseases (CRD), (iii) incidence ofaggregates
of GBM, (iv) incidence of CCM lesions, (v)
incidence of SqM lesions and (vi) micro-
scopically observed SqN. Standardsections
of the left and right lungs and post-caval
lobe (i.e. 3 sections in all) were evaluated
"blind" in respect of parameters (ii)-(vi).
CRD was assessed on the scale 0-4 (0
none, I = minimal, 2 = slight, 3 = of
moderate severity, 4 severe.) Various
kinds of spontaneous lung disease were
taken into account in arriving at a score
for each animal; e.g. aggregates of lym-
phocytes and plasma cells around main
airways and blood vessels, interstitial
pneumonitis, focal granulomatous lesions,
focal consolidation and bronchopneu-
monia. The score reflected both the
severity and extent of disease. Scores
for aggregates of GBM were allocated
as follows: 0 none, 1 occasional
10 42 7 157
clusters, 2 moderately frequent clus-
ters, 3 frequent clusters, 4 -_ very
numerous clusters, 5 = extensive masses
of pigment-laden macrophages. Scores for
CCM were based on the total numbers of
lesions observed in complete scan of the
left and right lung section up to a maxi-
mum of 25 lesions per lung. Large foci of
CCM were counted 2 x, 3 x, 4 X etc.,
according to the number of low-power
fields upon which they encroached. Scores
for SqM were arrived at in a directly
comparable way to that used for CCM.
All the squamous neoplasms (SqN) seen
were undoubtedly benign and were graded
"4". The mean diameters of SqN were
recorded.
Only 4 rats had lung tumours that were
visible at necropsy. All were among groups
treated with (R + P)G in infusine that
survived for the full 40 weeks of the
experiment. Further lung tumours lying
deep in the lung tissue were seen when the
lungs were trimmed after fixation. In
addition, several small SqN were discov-
ered for the first time during the micro-
scopic examination ofthe lungs. No animal
that died or was killed before the 40th
week of the experiment was found to have
an SqN, thoughthe 7 dyingbetween 20and
40 weeks were not examined microscopic-
ally. Table VI shows the incidence of SqN
among the 157 rats that were killed at 40
Gr-oup GI'U
1
3
4
5
6
7
8
9
10
11
12
13
14
15
No.
killed at
40 weeks
17
11
10
11
14
5
0
6
11
13
12
9
11
17
10
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TABLE VI. Incidence of Lung Tumours* among 157 Rats that were Killed at 40 WVeekst
Treatmeint
(mg 2 x weekly)
24'
12 (R + P)G in 36 infusine
N(QG) all dose levels
in inftusine
24'
12 P(R + )G in 6 BS/G
Anaesthetic Conitrols
No. of rats
killed
17
11
10
11
14
22
13
12
9
11
17
10
No. with
squamous
neoplasms
of lung
6
1
2
1
0
0
0
2
0
0
0
0
Total no.
of squamous
neoplasms
17
4
4
2
0
0
0
2
0
0
0
0
Sizes of laigest
squamous neoplasm
in each rat
(mean diameter in mm)
7,4-5,3, 1, 1, 1
2
3, 2
2
I,0 3
* Beinigni squamous neoplasms.
t No animal that dlied or was killed before 40 weeks had a macroscopically visible tumour, or was found
to have SqN on microscopic examination. Howrever, the 7 animals that died between 20 and 40 weeks
(see Table V) were not examined microscopically.
weeks. Altogether, 12 rats treated with
Fraction (R + P)G developed a total of
29 neoplasms, whereas none of the rats
given Fraction N(QG) did so. Ten of the
tumour-bearing rats were treated with
Fraction (R + P)G in infusine, which was
much more effective in giving rise to
neoplasms than the same fraction in BS/G.
Mean CRD scores tended to be slightly
lower in anaesthetic control rats (Group
15) than in other groups, but the severity
of CRD in the other groups was not
associated with kind of treatment, dose,
vehicle or time.
Zero or very low mean GBM scores
were a feature of the anaesthetic and
vehicle-only control groups (Groups 5,
14 and 15). Exposure to Fraction N(QG)
in I was associated with higher GBM
scores than exposure to (R + P)G in
either I or BS/G. (R + P)G in I and
(R A- P)G in BS/G gave similar GBM
scores. In the case of each kind of treat-
ment, GBM scores were dose and time
related.
Table VII summarizes the findings in
respect of CCM scores for animals killed at
1]0, 20 and 40 weeks. Treatment with
Fraction (R + P)G in either vehicle or
with Fraction N(QG) increased CCM score
in a dose-related and time-related fashion.
The response to Fraction (R + P)G in I
was significantly higher than that to the
same fraction in BS/G (P < 0 01) and
also significantly higher than that to
N(QGC) in the same vehicle (P < 0 001).
Table VIII summarizes the findings in
respect of SqM scores for rats killed at 10,
20 or 40 weeks. They are quite clear cut:
very low scores were a feature of the
anaesthetic controls, rats given either
vehicle only or Fraction N(QG) at any
dose level. By contrast, exposure to Frac-
tion (R + P)G was associatd with an
increase in SqM score which was markedly
time and dose related. Analysis ofvariance
showed that response to (R + P)G in I
was significantly (P = 0.01) greater than
that to (R + P)G in BS/G. With either
vehicle, an effect of 24 mg (R + P)G
twice weekly on SqM score was already
evident at 10 weeks.
Where post mortem change did not
obscure the picture, CCM and SqM scores
for animals dying before 10 weeks were
generally lower than those for animals
killed at 10 weeks, and scores for animals
dying between 10 and 20 weeks were
intermediate between those for animals
killed at 10 weeks and 20 weeks. None of
the 7 animals that died between 20 and 40
weeks was examined microscopically.
Group
2
3
4 5
6-9
10
11
12
13
14
15
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TABLE VII. Effect of Treatment on Incidence of Cuboidal/Columnar Metapla8sia of
Alveolar Epithelium (CCM Lesions). Mean Scores for Left and Right Lungs Com-
binedfor Rats Killed at 10, 20 and 40 Weeks
Treatment
(mg 2 x weekly)
24'
12 (R + P)Gin 6 infusine
0J
241.
12 N(QG) inI
6 infusine
3J
24)
12 t(R + P)G in 6 BS/G
Anaesthetic Control
CCM score at times shown (No. of rats)
r- -Aj
10 weeks
12-5 (6)
5-3 (6)
1-0 (6)
2-5 (4)
8-0 (4)
5-7 (6)
4-3 (6)
3 - 7 (3)
1-5 (6)
20 weeks
255- (6)
17-2 (6)
1- 3 (6)
16-0 (6)
7-3 (6)
5-2 (5)
2-5 (6)
40 weeks
46-8 (17)
43-2 (11)
22-4 (10)
24-7 (11)
4-2 (14)
34-6 (5)
19-5 (6)
14-0 (11)
43-5 (13)
37-4 (12)
25-9 (9)
18-2 (11)
3:9 (17)
2-5 (10)
TABLE VIII. Effect of Treatment on Incidence of Squamous M1vetaplasia of Alveolar
Epithelium (SqM). Mean Total Scoresfor Left and Right Lungs and Post-caval Lobe
for Rats Killed at 10, 20 and 40 Weeks
Group
1
2
.3
4
5
6
7
8
9
10
11
12
1:3
14
15
Treatment
(mg 2 x weekly)
24-
12 (R + P)G in
6 infusine
0
24
12 N(QG) in
6 infusine
:3
24
612 ( + P)G in BS/G
Anaesthetic only
SqM score at times shown (No. of rats)
10 weeks 20 weeks 40 weeks
0-8 (6) 3-2 (6) 205- (17)
0-2 (6) 0 3 (6) 13-0 (11)
6-9 (10)
6-4 (11)
0 0 (6) 0 0 (6) 0-6 (14)
0 *0 (4) 2 *0 (5) 0l0 (4)
0 7(6)
0.2 (6)
0 0 (3)
0.0 (6)
A "blind" evaluation of standard sec-
tions of the larynx and trachea revealed
no consistent differences between the
groups in terms of thickening of the
epithelium or inflammatory infiltration of
subepithelial layers. No examples of
squamous metaplasia of the laryngeal or
tracheal epithelium were encountered.
Macroscopic examination revealed no
treatment-related differences in incidences
of lesions outside the respiratory tract.
DISCUSSION
The results of the first experiment
indicated that Fraction (R + P)G, which
3-3 (6)
0.0 (7)
00 (6)
0 0 (6)
0 *3 (6)
0-1 (11)
15-2 (13)
6-1 (12)
2 - 9 (9)
1-0 (1)
0.-4 (17)
0-2 (10)
forms only 3.5O% of whole-smoke conden-
sate and is almost as tumorigenic for
mouse skin as the much larger mass of
whole-smoke condensate from which it is
derived (Lee et al., 1977) when instilled
twice-weekly into the lungs of rats, in-
creased the incidence of squamous meta-
plasia of alveolar epithelium (SqM) and
of squamous neoplasms (SqN), both in-
creases being dose-related, though in the
case of SqN this was not statistically
significant. Instillation of Fraction (R +
P)G also increased the incidence of 2
other lesions: aggregates of alveolar
macrophages containing golden-brown
Grouip
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pigment (GBM) and foci of cuboidal/
columnarmetaplasiaofalveolarepithelium
(CCM). This increase was time-related but
apparently irrespective of dose, although
the apparent lack of dose response may
have been due to the response being
maximal at the lowest dose studied. Some
of the SqN observed were doubtfully
malignant, butnounequivocallymalignant
lung tumour was seen. However, only 5
treated rats survived for longer than 60
weeks.
The second main experiment showed
that, whereas a fraction of cigarette-
smoke condensate (Fraction (R + P)G)
which is relatively strongly tumorigenic
for mouse skin gives rise to SqM and SqN
when instilled into the lungs of rats,
another fraction (Fraction N(QG)) which
is more or less without tumorigenicity for
mouse skin, was almost entirely unable to
induce SqM or SqN when instilled into the
lungs of rats. By contrast, both fractions
were active in causing GBM and CCM,
suggesting that these lesions are not
specific to the tumour process.
An important aspect of the findings is
that the effect of Fraction (R + P)G on
the incidence of SqM was already evident
at 10 weeks. This may mean thatthe intra-
tracheal instillation technique with SqM
as the end point could be used as a short-
term test for predicting tumorigenicity of
smoke components.
In the case of mouse skin, there is
evidence that the tumorigenic activity of
Fractions (R + P)G from different smoke
condensates parallel the activities of the
smoke condensates from which they are
derived (Lee et al., 1977). If this is as true
for rat lung as for mouse skin, tests on rat
lung of Fraction (R + P)G from different
condensates might be useful for comparing
the overall tumorigenicity of different
condensates.
In neither of the 2 studies reported was
it possible to keep more than a few
animals for long-term observation. It is
perhaps not surprising, therefore, that no
unequivocally malignant lung tumour was
seen.
Further studies will be needed to see
how useful a predictor of tumorigenicity
the rat lung instillation assay is, and
whether truly malignant lung neoplasms
can be induced by this method.
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